COVID-19 related inflammation as a risk factor for age-related cognitive decline and Alzheimer's Disease
COVID-19 相关炎症是与年龄相关的认知能力下降和阿尔茨海默病的危险因素
基本信息
- 批准号:10646590
- 负责人:
- 金额:$ 23.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAPP-PS1AccelerationAdultAge-associated memory impairmentAgingAgonistAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskBehavioralBrainCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 survivorsDataDementiaDisease ProgressionFemaleFutureGene Expression ProfilingGenotypeGoalsHippocampusImmuneImmune signalingImpaired cognitionIndividualInflammationInflammatoryInjuryInterferon Type IKnowledgeLaboratoriesLipopolysaccharidesLong COVIDLong-Term EffectsMediatingMemoryMemory DisordersMemory LossMemory impairmentMicrogliaMolecular AnalysisMusNerve DegenerationNeuroimmuneNeuroimmunomodulationNeuronal PlasticityPathway interactionsPersonsPlayPopulationPrevention strategyPreventive treatmentProcessProtein BiochemistryProtocols documentationRNA VirusesRecoveryReportingResearchResolutionRiskRisk FactorsRisk ReductionRoleSenile PlaquesSex DifferencesSignal TransductionSurvivorsSymptomsTLR3 geneTLR4 geneTLR7 geneTLR8 geneTestingTimeTransgenic MiceVirusWild Type MouseWomanWorkage relatedbehavior testbeta amyloid pathologychemokinecognitive functioncoronavirus diseasecytokinedementia riskimmune activationmalemiddle agemouse modelneuroinflammationnovelpandemic diseasepost-COVID-19sextau aggregationyoung adult
项目摘要
PROJECT SUMMARY
More than 85 million cases of COVID-19 have been recorded in the US alone, and up to 40% of survivors
report Long-COVID symptoms including cognitive impairments. Together with evidence that inflammation
during adulthood increases risk for later cognitive decline, this raises the prospect that the COVID-19
pandemic will cause a future “second pandemic” in Alzheimer’s disease and age-related dementias. In this
project, we will identify specific mechanisms by which single stranded RNA (ssRNA) viruses (e.g., SARS-COV-
2) triggered innate immune signaling contributes to long-lasting memory impairments, exaggerated cognitive
decline during aging, and risk for dementias including Alzheimer’s disease. Our main goal is to determine the
impact of innate immune signaling as a consequence of ssRNA viruses on exaggeration of age-related
cognitive decline and risk for dementias including Alzheimer’s Disease. We will use a subchronic inflammation
protocol, established in my laboratory, together with behavioral tests of memory, protein biochemistry, and
gene expression assays to identify persistent changes in inflammatory state and neuroplasticity mechanisms
that exacerbate cognitive decline. We will use wild-type mice and APP/PS1 transgenic mice to determine
whether TLR7-induced inflammation causes acceleration of age-related cognitive decline and AD-like
pathology. Findings from this project will demonstrate how COVID-19, and other TLR7-induced inflammation
increases risk for dementia; identify sex differences in COVID-related vulnerability to cognitive decline; and
provide a basis for novel preventive strategies and treatments to reduce risk for Alzheimer’s disease and other
dementias in the post-COVID-19 population.
项目摘要
仅在美国,就已经记录了超过8500万例Covid-19案件,最多40%的幸存者
报告长舒联症状,包括认知障碍。以及炎症的证据
在成年期间增加了后来认知能力下降的风险,这提高了Covid-19的前景
大流行将在阿尔茨海默氏病和与年龄有关的痴呆症中引起未来的“第二大流行”。在这个
项目,我们将确定单个链RNA(SSRNA)病毒(例如SARS-COV-)的特定机制
2)触发先天免疫信号传导有助于长期记忆障碍,夸张的认知
衰老期间的下降以及包括阿尔茨海默氏病在内的痴呆症风险。我们的主要目标是确定
ssRNA病毒对先天免疫信号传导的影响对年龄相关的夸张
包括阿尔茨海默氏病在内的痴呆症的认知能力下降和风险。我们将使用亚慢性炎症
协议,在我的实验室中建立,以及记忆,蛋白质生物化学和
基因表达分析以识别炎症状态和神经塑性机制的持续变化
这种加剧的认知能力下降。我们将使用野生型小鼠和App/ps1转基因小鼠来确定
TLR7诱导的炎症是否会导致与年龄相关的认知下降和类似AD的加速
病理。该项目的发现将证明COVID-19和其他TLR7诱导的炎症如何
增加痴呆症的风险;确定与认知下降的脆弱性相关脆弱性的性别差异;和
为新颖的预防策略和治疗提供了基础,以降低阿尔茨海默氏病和其他的风险
199年后人口的痴呆症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natalie Celia Tronson其他文献
Natalie Celia Tronson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natalie Celia Tronson', 18)}}的其他基金
Cytokine Signaling as a Mediator of Fear and Anxiety After Myocardial Infarction
细胞因子信号传导作为心肌梗死后恐惧和焦虑的调节剂
- 批准号:
8092144 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
Cytokine Signaling as a Mediator of Fear and Anxiety After Myocardial Infarction
细胞因子信号传导作为心肌梗死后恐惧和焦虑的调节剂
- 批准号:
8519638 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
Cytokine Signaling as a Mediator of Fear and Anxiety After Myocardial Infarction
细胞因子信号传导作为心肌梗死后恐惧和焦虑的调节剂
- 批准号:
8235843 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
Cytokine Signaling as a Mediator of Fear and Anxiety After Myocardial Infarction
细胞因子信号传导作为心肌梗死后恐惧和焦虑的调节剂
- 批准号:
8538503 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
相似海外基金
Behavioral and physiological measurements of hearing in mouse models of Alzheimer's Disease
阿尔茨海默病小鼠模型听力的行为和生理测量
- 批准号:
10647340 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease
线粒体脂质组动力学及其与 APOE 亚型的相互作用对脑衰老和阿尔茨海默病的影响
- 批准号:
10645610 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Drug repurposing for Alzheimer’s disease-related inflammation caused by a TBI
药物再利用,治疗 TBI 引起的阿尔茨海默病相关炎症
- 批准号:
10590132 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Environmental factors in pathobiology of dementia: the role of PCB exposure, microbiome, and tissue barrier dysfunction
痴呆病理学中的环境因素:PCB 暴露、微生物组和组织屏障功能障碍的作用
- 批准号:
10558120 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
- 批准号:
10718104 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别: